| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |